Pet 2-fluoro-2-deoxyglucose uptake in rat prostate adenocarcinoma during chemotherapy with gemcitabine

Journal of Nuclear Medicine

Volumn 38, Issue 8, 1997, Pages 1215-1221

  Haberkorn, Uwe ^a   Bellemann, Matthias E ^a   Altmann, Annette ^a   Gerlach, Ludwig ^a   Morr, Iris ^a   Oberdorfer, Franz ^a   Brix, Gunnar ^a   Doll, Josef ^a   Blatter, Johannes ^a   Van Kaick, Gerhard ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Chemotherapy; Fluorine 18 FDG; Gemcitabine; PET; Prostate adenocarcinoma

Indexed keywords

3 METHYLGLUCOSE; FLUORODEOXYGLUCOSE F 18; GEMCITABINE; THYMIDINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG TRANSPORT; DRUG UPTAKE; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; RAT;

ADENOCARCINOMA; ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; BIOLOGICAL TRANSPORT; DEOXYCYTIDINE; DEOXYGLUCOSE; DNA, NEOPLASM; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; GLUCOSE; MALE; NEOPLASM TRANSPLANTATION; PROSTATIC NEOPLASMS; RADIOPHARMACEUTICALS; RATS; RIBONUCLEOTIDE REDUCTASES; THYMIDINE; TOMOGRAPHY, EMISSION-COMPUTED; TRITIUM; TUMOR CELLS, CULTURED;

EID: 0030769347     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Gandhi V, Plunkett W. Modulatory activity of 2',2'-difluorodeoxycytidine on the phosphorylation and cytotoxicity of arabinosyl nucleosides. Cancer Res 1990;5(): 3675 3680.
2. Grunewald R, Kantarjian H, Keating MJ, Abbruzzese J, Tarasoff P, Plunkett W. Pharmacologically directed design of the dose rate and schedule of 2',2'-difluorodeoxycytidine (gemcitabine) administration in leukemia. Cancer Rex 1990;50:6823 6826.
3. Minn H, Paul R, Ahonen A. Evaluation of treatment response to radiotherapy in head and neck cancer with fluorine-18 fluorodeoxyglucose. J Nucl Med 1988;29:1521 1525.
4. Wahl RL, Zasadny K, Helvie M, Hutchins GD, Weber B, Cody R. Metabolicmonitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation. ./ Clin Oncol 1993;! 1:2101 2111.
5. Rozenthal JM, Levinc RL, Nickles RJ, Dobkin JA. Glucose uptake by gliomas after treatment. Arch Neurol 1989;46:1302-1307.
6. Haberkorn U, Strauss LG, Dimitrakopoulou A, et al. Fluorodeoxyglucose imaging of advanced head and neck cancer after chemotherapy. J Nucl Med 1993;34:12-17.
7. Haberkorn U, Strauss LG, Dimitrakopoulou A, et al. PET studies of fluorodeoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy. ./ Nucl Med 1991 ;32:1485 1490.
8. Oberdörfer F, Hull WE, Traving BC, Maier-Borst W. Synthesis and purification of 2-deoxy-2-'8fluoro-D-glucose and 2-deoxy-2-ifluoro-D-mannose: characterization of products by 'H and '''F-NMR spectroscopy. to./ Appl Radial hot 1986;37:695-701.
9. Hoverath H, Kubier WK. Ostertag HJ, et al. Scatter correction in the transaxial slices of a whole-body positron emission tomograph, t'hvx Med Biol 1993;38:717 728.
10. Ostertag H, Kubier WK, Doll J, Lorenz WJ. Measured attenuation correction methods. EurJ Nucl Med 1989;15:722 726.
11. Bellemann ME, Doll J, Brix G, et al. PET image reconstruction for pharmacokinetic modeling of 5-[lsF]fluorouracil in liver tumors. In: Bergmann H, Sinzinger H, eds. Radioactive Isotopes in Clinical Medicine and Research. Basel, Switzerland: Birkhauser; 1995:79 84.
12. Brix G. Doll .1, Bellemann ME. et al. Use of scanner characteristics in iterative image reconstruction for high-resolution PET studies of small animals. Ear Nucl Med 1997: in press.
13. Shepp LA, Vardi Y. Maximum likelihood reconstruction for emission tomography. IEEE Trans Med Imaging 1982; 1:113-122.
14. Phelps ME, Huang SC, Hoffman EJ, Selin C, Sokoloff L, Kühl DE. Tomographie measurement of local cerebral glucose metabolic rate in humans with (F-l8)2-fluoro2-deoxy-D-glucose: validation of method. Ann Neurol 1979:6:371-388.
15. Huang SC, Phclps ML-:. Lloffman LU, Siclcris K. Selin CJ, Kühl DL-:. Noninvasive determination of local cérébral metabolic rate of glucose in man. Am J Phvsiol 1980;238:E69 F.82.
16. Haberkorn U, Reinhard! M. Strauss LG. et al. Metabolic design of combination therapy: use of enhanced lluorodeoxyglucose uptake caused by chemotherapy../ Nucl Med 1992;33:1981 1987.
17. Habcrkom U, Oberdorfer F, Kienner T. et al. Metabolie and transcriptional changes in osteosarcoma cells treated with chemotherapeutic drugs. Nucl Med Biol 1994;21:835 845.
18. D'Argenio DZ, Schutnitzky A. ADAPT II User's Guuie. Los Angeles: Biomédical Simulation Resource, University of Southern California; 1992.
19. Sachs L. Angewandte Statistik. Berlin: Springer; 1984: 329-333.
20. Higashi K. Clavo AC. Wahl R. In vitro assessment of 2-fluoro-2-deoxy-D-glucose. L-methionine and thymidine as agents to monitor the early response of a human adenocarcinoma cell line to radiotherapy. J Nucl Med 1993;34:773 779.
21. Keyes JW. SUV: standardiJ.ed uptake or silly useless value? J Nucl Med 1995;36: 1836 1839.
22. Lacko L, Wittke B. Krornphardt H. Kinetics of glucose uptake in erythrocytes: effect of trans-concentration. Kur J Bioclwm 1972;25:447 454.
23. Haberkorn U, Morr l. Oberdorfer F. et al. Fluorodeoxyglucose uptake in vitro: aspects of method and effects of treatment with gemeitabine. J Nucl Med 1994;35:1842 1850.
24. Slosman DO, Pugin .1. Lack of correlation between tritiated deoxyglucose, thallium201 and technetium-99m-MILM cell incorporation under various cell stresses. Eur J Nucl Med 1994;35:120 126.
25. Minn H. Kangas L.. Kellokumpu-Lchtinen P, et al. Uptake of 2-fluoro-2-deoxy-D-(Ul4C)-glucose during chemotherapy in marine Lewis lung tumor. Nucl Med Biol 1992;19:55 63.
26. Hayes N. Biswas C, Strout V, Berger J. Activation by protein synthesis inhibitors of glucose transport into L6 muscle cells. Kiochem Biophvs Res Commun 1993; 190:881 887.
27. Shawver LK, Oison SA, White MK, Weber MJ. Degradation and biosynthesis of the glucose transporter protein in chicken embryo fibroblasts transformed by the src oncoL'cnc. Mol Cell Hint 19X7:7:21 12-21 18.
28. Widncll CC, Baldwin SA, Davies A, Martin S, Pasternak C'A. Cellular stress induces a redistribution of the glucose transporter. FASKB J 1990;4:1634 1637.
29. Pasternak CA, Aiyathurai JHJ, Makinde V. Regulation of glucose uptake by stressed cells. ,/ Cell Physiol 1991:149:324-331.
30. C'lancy BM, Czech MP. Hexose transport stimulation and membrane redistribution of glucose transporter isoibrms in response to cholera toxin, dibutyryl cyclic AMP and insulin in 3T3 adipoeytes. J Biol Chem 1990:265:12434- 12443.
31. Flier JS. Mueekler MM, Usher P, Lodish HF. Elevated levels of glucose transport and transporter messenger RNA are induced by ras or s re oncogenes. Science 19X7:235: 1492 1495.
32. Hughes CS. Shen JW, Subjeck JR. Resistance to etoposide induced by three glucose-regulated stresses in Chinese hamster ovary cells. Cancer Re\ 1989:49:4452 4454.
33. Wertheimer E, Sasson S, Cerasi E, Ben-Neriah Y, The ubiquitous glucose transporter GLUT-1 belongs to the glucose-regulated protein family of stress-inducible proteins. Proc Natl Acud Sei USA 1991:88:2525-2529.
34. Christman D, Crawford EJ, Friedkin M, Wolf AP. Detection of DNA synthesis in intact organisms with positron-emitting (methyl-C)thymidine. Proc Mall Acail Sei USA 1972:69:988-992.
35. Poupeye EM, Goethals PP, Dams RF, De Leenheer AP. van Kijkeren ME. Evaluation of (C)thymidine for measurement of cell proliferation in fast dividing tissues. Nuel Med Biol 1993:20:359- 362.
36. Shields AF, Coonrod DV, Quackenbush RC, Crowley .1,1. Cellular sources of thymidine nucleotides: studies for PET. ./ Nuel Med 1987:28:1435 1440.
37. Shields AF. I.im K, Grierson .1, Link J, Krohn KA. Utilization of labeled thymidine in DNA synthesis: studies for PET. ./ Nuel Med 199Ü;31:337 342.
38. Vander Borght TM. Lambotte LE, Pauwels SA. Dive CC. Uptake of thymidine labeled on carbon 2: a potential index of liver regeneration by positron emission tomography. Heputology 1990:12:113 118.
39. Shields AF. Grierson JR, Kozawa SM, Zheng M. Development of labeled thymidine analogs for imaging tumor proliferation. Nuel Med Biol 1996:23:17 22.